Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002394151 | SCV002668673 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-07-31 | criteria provided, single submitter | clinical testing | The p.A253E variant (also known as c.758C>A), located in coding exon 9 of the BRCA1 gene, results from a C to A substitution at nucleotide position 758. The alanine at codon 253 is replaced by glutamic acid, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV002394151 | SCV003847963 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |